Data relating to the use of digoxin from a descriptive epidemiological study of drug use in residential homes for elderly people were analysed. Of the 1,888 residents in the study homes, 212 were receiving cardiac glycosides. The ratio of females to males who received cardiac glycosides was 2.8:1; however, this was not statistically significant as it reflected the overall population. The median age of recipients of cardiac glycosides was 85.2 years and they were significantly older than non-recipients (P<0.001). The cardiac glycosides were almost exclusively prescribed as digoxin, the median dose was 125 pg with a range of 62.5' to 250 pg, and the median duration of treatment was 2.3 years, range <0.1 to 10.1 years. Digoxin was involved in a total of 152 potential drug interactions, 12 of which were potentially highly significant clinically.
Introduction
Individuals 60 years of age or older are at increased risk from drug treatment due to a reduced ability to handle drugs and increased sensitivity to pharmacological effects. 1-3 Adverse drug reactions have been reported as less than 3% in persons aged 20 to 29 years but as high as 21% in those over 70 years of age.4 '5 Cardiac glycosides are among the most commonly used drugs in elderly patients and diminished excretion in the elderly predisposes the patient to serious adverse effects. The incidence of digoxin toxicity is estimated at between 23 to 30%. [6] [7] [8] [9] [10] The higher incidence of toxicity associated with digoxin in older patients is more closely related to reduced renal function, accompanied by higher and more prolonged serum concentrations, than to an increased sensitivity of the heart to the action of the drug.11
It has been suggested that the use of maintenance digoxin is often unnecessary.12 '13 In several studies digoxin therapy was withdrawn from elderly patients without detriment'4'15 and DallI6 showed that of a group of patients on long-term digoxin therapy, 75% suffered no harm through digoxin therapy being stopped.
When continuing digoxin therapy is indicated, it should be given in smaller doses in older patients,17 yet a study, designed specifically to assess the use of digoxin in a group of 42 elderly patients, revealed that only 1 in 3 were receiving an appropriate dose. 1 8 While the majority of the elderly live in the community in their own homes and only a small proportion (approximately 5%) live in residential accommodation, the latter are a unique population in that they are a 'captive' group in which compliance with drug treatment can be ensured by staff in the home. These elderly people appear to have minimal contact with their general medical practitioner and pharmacist, since surrogates order, collect and administer their medicines. There is, however, a lack of detailed studies of drug use by elderly people in residential homes.1 [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] [21] [22] [23] In the present study, which was designed to provide information on drug usage in the elderly, an assessment was made of the extent and appropriateness of the use of cardiac glycoside medicines by elderly people in residential homes.
Methods
Fifty-five residential homes in two local authorities were visited in 1984 over a 6-month period and data were obtained from the officers-in-charge, the drug administration records and the stock of medicines held in the home. (Table II) . These were assessed for clinical significance. 26 Twelve of these may have been highly clinically significant. However the retrospective nature of the study meant that this could not be confirmed clinically. Residents. on digoxin took a relatively large number of other medicines, so this high incidence of clinically significant drug interactions is not surprising and highlights the need for careful review of the use of digoxin and concurrent medication in the elderly.
Discussion
In the present investigation 1,502 medicines acting on the cardiovascular system (representing 27.1% of all medicines used) were received by 933 residents, nearly 50% of the entire population studied. This figure is in close agreement with Allwood et al.27 who reported that 25.3% of medicines for the elderly were cardiovascular medicines and Vener et al.28 who reported 22.8%. Diuretics were the most frequently used cardiovascular medicine (59.5%) followed by cardiac glycosides (14.1%), vasodilators (8.2%), betablockers (2.7%) and antihypertensives (others) (1.7%).
Probably more has been written about the use of digoxin in the elderly than almost any other single drug. Yet despite the amount of available literature there is still some controversy about whether maintenance digoxin therapy should be used, in what dose and for what duration.
For many years digoxin was considered the most appropriate treatment for congestive heart failure; however, this view has been challenged with diuretics being promoted as the treatment of choice for mild to moderate cardiac failure. 29 The use of maintenance digoxin for cardiac failure in sinus rhythm is subject to debate. Studies have shown that digoxin can be discontinued in 75%16 to 86% of patients,30 the commonest cause of lack of success being atrial fibrillation. In the present study over 50% of available diagnoses indicated that digoxin was used for congestive heart failure and approximately 20% for atrial fibrillation.
Ewy et al. 31 have demonstrated that within 24 hours after intravenous administration, serum digoxin levels were nearly twice as high in elderly Code for clinical significance: 1 -highly clinically significant; 2 -moderately clinically significant; 3 -minimally clinically significant. patients as in younger subjects given the same dose. Similarly another study32 found that the volume of distribution of digoxin is 40% lower in older than in younger patients. These findings indicate that lower doses than the standard adult dose of digoxin are appropriate for the elderly. The usual maintenance dose of digoxin in very old patients should be 125 pg daily and toxicity is common in those given 250pg daily (BNF33). However in the present study 44 (21%) patients were receiving more than 125 pg daily and 40 (19%) were receiving 250 pg or more daily.
In the present study digoxin was involved in 152 potential drug-drug interactions which represented nearly 30% of all 509 possible potential drug-drug interactions. Digoxin was always the drug affected, the majority of the interactions increasing the serum levels of digoxin leading to the possibility of digoxin toxicity. This level of potential drug-drug interactions involving digoxin is a cause for concern given that 12 of the interactions were deemed to be potentially highly clinically significant.
Because oedema is usually associated with congestive cardiac failure, digoxin is frequently prescribed along with a diuretic. Potassium loss frequently occurs in elderly patients with a thiazide diuretic34 and since the toxicity of digoxin is inversely related to serum potassium levels, this could cause problems. In the present study, there were 76 potential clinically significant drug-drug interactions due to the combined use of digoxin with a diuretic.
It has been stated in an editorial in the Lancet35 that the principle 'once on digoxin, always on digoxin' is no longer good practice. The findings from the present study indicate that there is a need for a review of the effectiveness and toxicity of maintenance digoxin treatment in elderly people.
